ICON Q2 Revenue Reaches $2.06B, but Earnings Erode on Higher Costs and a $32.9M Disposal Loss
ICLR has more than doubled off its 52-week low of $66.57.
Summary
ICON posted Q2 revenue of $2.06 billion and EPS of $0.94, but earnings dropped sharply due to higher costs and a $32.9 million loss on the Symphony Health Solutions disposal. The company also refinanced $500 million in maturing debt with a bridge loan.
Key Events · Earnings and Guidance · ICLR
-
Q2 Revenue Up, Earnings Down
Revenue rose 1.2% to $2.06 billion, but net income fell 64% to $72.6 million ($0.94 diluted EPS) as direct costs increased to 76.8% of revenue and a $32.9 million loss on the Symphony disposal weighed on results.
-
Symphony Disposal Completed at a Loss
ICON completed the disposal of Symphony Health Solutions on May 8, 2026, recording a pre-tax loss of $32.9 million. The company received nominal consideration and holds a minority stake in HealthVerity, carried at $nil.
-
Bridge Loan Drawn to Repay Maturing Notes
On July 15, 2026, ICON drew down the full $500 million Bridge Secured Credit Facility to repay the $500 million 2.875% Senior Secured Notes that matured the same day. The bridge loan matures April 26, 2027.
-
Securities Class Action Expands
On June 26, 2026, lead plaintiffs filed a Second Amended Complaint adding the current CFO and a former employee as defendants, and asserting new 'scheme liability' claims. ICON's motion to dismiss is due by September 1, 2026.
Analysis · ICLR · Industrial Applications And Services
ICON's second quarter presents a mixed narrative: revenue edged up 1.2% to $2.06 billion, yet net income tumbled 64% to $72.6 million as direct costs climbed and a $32.9 million loss on the Symphony disposal carved into the bottom line. The company also tapped a $500 million bridge loan to retire maturing notes, adding near-term debt. Against a backdrop of recent restatements and a Nasdaq non-compliance notice, these results offer a critical update on operational stability, though margin pressure and litigation risks remain key concerns.
How filings like this one have moved
In the 30 days to Sep 12, 2026, 35.6% of the 1569 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.19%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ICLR was trading at $182.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $13.6B. The 52-week trading range was $66.57 to $203.91. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.